During the past decade, London Road Diagnostic Clinic and Medical Centre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 10 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "London Road Diagnostic Clinic and Medical Centre" #1 sponsor was "Pfizer" with 5 trials, followed by "Dynogen Pharmaceuticals" with 3 trials sponsored, "Mannkind Corporation" with 3 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored and "Acasti Pharma Inc." with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "London Road Diagnostic Clinic and Medical Centre" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator, "JSS Medical Research Inc." with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "London Road Diagnostic Clinic and Medical Centre" are "Irritable Bowel Syndrome" (3 trials), "Cardiovascular Disease" (2 trials), "Arthritis, Rheumatoid" (1 trials), "Asthma" (1 trials) and "Chronic Idiopathic Constipation" (1 trials). Many other conditions were trialed in "London Road Diagnostic Clinic and Medical Centre" in a lesser frequency.

Most popular intervention types in "London Road Diagnostic Clinic and Medical Centre" are "Drug" (15 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "DDP733" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Bococizumab (PF-04950615; RN316)" (1 trials) and "CaPre (TM)" (1 trials). Other intervention names were less common.

The vast majority of trials in "London Road Diagnostic Clinic and Medical Centre" are 16 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "London Road Diagnostic Clinic and Medical Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in London Road Diagnostic Clinic and Medical Centre, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in London Road Diagnostic Clinic and Medical Centre, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".